Wooree Group is combining overseas expansion with a proposed scientific validation framework for liposomal products. At Vitafoods Asia 2026 in Bangkok, CEO Ji-yong Yoon presented the Six Pillars, covering liposome structure, particle characteristics, encapsulation efficiency, shelf stability, gastrointestinal stability and pharmacokinetic evaluation of bioavailability. The group's LIPOPRIME brand covers approximately 40 ingredients, with selected products showing particle concentrations up to 24 times higher than competing market alternatives in nanoparticle tracking analysis. Wooree plans to enter overseas markets first through liposome ingredient exports, prioritizing the United States before expanding into OEM, ODM and branded products. Bio revenue rose from 15.5 billion won in 2021 to 63.5 billion won in 2025.